Log In
BCIQ
Print this Print this
 

MM-151

  Manage Alerts
Collapse Summary General Information
Company Adimab LLC
DescriptionMixture of 3 IgG1 mAbs against non-overlapping epitopes of human epidermal growth factor receptor 1 (EGFR1; HER1; ErbB1)
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$14.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/05/2011

Undisclosed

0

$14.0M

Get a free BioCentury trial today